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H]thiamine uptake compared with cell exposure to a high level of thiamine (1 mM). This adaptive regulation was also associated with a higher level of mRNA expression of thiamine transporter-2 (THTR-2), but not thiamine transporter-1 (THTR-1), in the deficient condition and a higher level of promoter activity of gene encoding THTR-2 (SLC19A3). Using 5=-truncated promoter-luciferase constructs, we identified the thiamine level-responsive region in the SLC19A3 promoter to be between Ϫ77 and Ϫ29 (using transcriptional start site as ϩ1). By means of mutational analysis, a key role for a stimulating protein-1 (SP1)/guanosine cytidine box in mediating the effect of extracellular thiamine level on SLC19A3 promoter was established. Furthermore, extracellular level of thiamine was found to affect SP1 protein expression and binding pattern to the thiamine level-responsive region of SLC19A3 promoter in Caco-2 cells as shown by Western blotting and electrophoretic mobility shift assay analysis, respectively. These studies demonstrate that the human intestinal thiamine uptake is adaptively regulated by the extracellular substrate level via transcriptional regulation of the THTR-2 system, and report that SP1 transcriptional factor is involved in this regulation.
SLC19A2; SLC19A3; transporter; stimulating protein-1; thiamine transporter-2 MAMMALIAN CELLS HAVE AN ABSOLUTE requirement for thiamine (vitamin B 1 ) to maintain their normal functions, growth, and development. Thiamine (mainly in its pyrophosphate form) acts as an enzymatic cofactor for transketolase, pyruvate dehydrogenase, ␣-ketoglutarate dehydrogenase, and branchedchain ketoacid dehydrogenase, enzymes involved in many critical metabolic reactions that relate to energy metabolism (1) . Because thiamine is also known to function as a bridge between the glycolytic and the pentose phosphate metabolic pathways (which generate chemical-reducing power in the cell), it is assumed to play an important role in reducing cellular oxidative stress (2, 8) . Thus, low intracellular levels of thiamine will lead to impairment in energy metabolism (acute energy failure) and to a propensity for oxidative stress. Systemically, thiamine deficiency in humans leads to a variety of clinical abnormalities, including neurological (neuropathy and/or Wernicke-Korsakoff syndrome) and cardiovascular (e.g., peripheral vasodilatation, biventricular myocardial failure, edema, and potentially acute fulminant cardiovascular collapse) disorders (1, 33, 36) . On the other hand, optimization of thiamine level seems to have the potential in preventing diabetic retinopathy and blocking tissue damage caused by hyperglycemia of diabetes (10) ; it is also effective in the treatment of many clinical symptoms related to the autosomal recessive disorder, thiamine-responsive megaloblastic anemia (also known as Roger's Syndrome) (16, 19) , a condition caused by mutations in thiamine transporter-1 (THTR-1) (4, 7). Thiamine deficiency and suboptimal levels represent significant nutritional problems in both developing and developed countries. In developing countries, these conditions occur mainly due to malnutrition, whereas chronic alcoholism is the main cause of thiamine deficiency in the developed countries (12, 31, 34, 35) . Deficiency and suboptimal levels of thiamine also occur in patients with diabetes mellitus (27) , inflammatory bowel disease (6), celiac disease (34) , and renal diseases (18) . In addition, deficiency of thiamine has been reported in the elderly despite an average daily intake of the vitamin that exceeds the recommended requirement (17) .
Humans (and all other mammals) cannot synthesize thiamine and thus, must obtain the vitamin from exogenous sources via intestinal absorption. The intestine, therefore, plays a critical role in maintaining and regulating normal thiamine body homeostasis. With the use of a variety of intestinal preparations, previous studies have shown that the intestinal thiamine uptake process occurs via a specific carrier-mediated process and involves both THTR-1 and thiamine transporter-2 (THTR-2) (products of the SLC19A2 and SLC19A3 genes) (5, 20, 21, 26, 28) . Other studies have shown that the THTR-1 protein is expressed at both the apical and the basolateral membrane domains of the polarized enterocytes, whereas the THTR-2 is restricted only to the apical membrane domain of these cells (26, 28, 29) .
Knowledge about how the intestinal thiamine uptake process is regulated has also been emerging in recent years (15, (22) (23) (24) (25) . Thus, in previous studies from our laboratory, we examined the effect of thiamine level (deficiency) in the diet on intestinal absorption of the vitamin. We used wild-type and transgenic mice carrying the human SLC19A2 and SLC19A3 promoters in our investigations. The results showed that the intestinal thiamine uptake process is adaptively regulated by substrate level in the diet and that this regulation is mediated, at least in part, via a transcriptional mechanism (23) . Similarly, a study on intestinal thiamine uptake in a thiamine-deficient human subject has shown that the process is adaptively regulated (11) . The molecular basis of this adaptive regulation in intestinal thiamine uptake, however, is not fully understood and was therefore investigated in this study using the human-derived intestinal epithelial Caco-2 cells as a model. The results show that the adaptive regulation of intestinal thiamine uptake process by substrate level is mediated via a transcriptional mechanism affecting the THTR-2 system and involves the transcriptional factor stimulating protein-1 (SP1).
MATERIALS AND METHODS

Materials.
Human-derived intestinal epithelial Caco-2 cells were purchased from American Type Culture Collection (Manassas, VA). [ 3 H]thiamine (specific activity: Ͼ20 Ci/mmol, radiochemical purity: Ͼ98%) was purchased from American Radiolabeled Chemical (St. Louis, MO). Anti-SP1 rabbit polyclonal antibody (catalog no. SAB4502836) was obtained from Sigma (St. Louis, MO). Anti-SP1 monoclonal (catalog no. SC-420X) and anti-␤-actin monoclonal (catalog no. SC-47778) antibody were obtained from Santa Cruz Biotechnology (Santa Cruz, CA). Anti-rabbit IRDye-800 and anti-mouse IRDye-680 antibodies were from LI-COR Bioscience (Lincoln, NE). The synthetic oligonucleotides for electrophoretic mobility shift assay (EMSA) were purchased from Sigma Genosys (Woodlands, TX). Routine biochemicals, cell culture reagents, and transfection reagents were all of molecular biology quality and were purchased from Fisher Scientific (Tustin, CA), Sigma, and Life Technologies (Rockville, MD).
Cell growth and thiamine uptake assays. Caco-2 cells (passages 20 -40) were grown in DMEM supplemented with 10% (vol/vol) FBS, glutamine (0.29 g/l), sodium bicarbonate (2.2 g/l), penicillin (100,000 U/l), and streptomycin (10 mg/l) for regular maintenance. In the studies to investigate the effect of extracellular thiamine level on [ 3 H]thiamine uptake and related parameters, the cells were plated at a density of 2 ϫ 10 5 cells/well on 12-well plates and were grown for 9 days in custom-made thiamine-deficient DMEM (Life Technologies) supplemented with 2.5% dialyzed FBS (Hyclone) with media changes every 1-2 days. In our preliminary studies, we used the shorter time periods (3-7 days) but found that cells exposed to different extracellular level of thiamine demonstrated more profound effect in thiamine uptake after a longer (9 days) period (data not shown); thus, a 9-day incubation period was chosen. (25, 26) . [ 3 H]thiamine (21 nM) was added to the incubation medium at the onset of the uptake experiment, and at the end of the incubation period the reaction was terminated by ice-cold buffer. Cells content of radioactivity was determined using a Beckman Coulter LS6500 multipurpose scintillation counter (Fullerton, CA). Protein was measured in parallel wells using a Bio-Rad DC Protein Assay kit (Bio-Rad).
Real-time PCR analysis. Total RNA isolated from Caco-2 cells was subjected to reverse transcription using the iScript cDNA synthesis kit (Bio-Rad, Hercules, CA). The mRNA expression level was quantified in a CFX96 real-time PCR system (Bio-Rad) using iQ SYBR Green Supermix (Bio-Rad) and primers specific for hTHTR-1 (forward: 5=-AGCCAGACCGTCTCCTTGTA-3= and reverse: 5=-TAGA-GAGGGC-CCACCACAC-3=), hTHTR-2 (forward: 5=-TTC-CTGGATTTAC-CCCACTG-3= and reverse: 5=-GTATGTCC-AAACGGGGAAGA-3=), and ␤-actin (forward: 5=-AGCCAGACCGTCTCCTTGTA-3= and reverse: 5=-TAGAGAGGGCCCACCACAC-3=). Real-time PCR conditions were as previously described (23) , and data normalized to ␤-actin were calculated using a relative relationship method supplied by the iCycler manufacturer (Bio-Rad).
Transfection and reporter gene assay. Caco-2 cells (ϳ80% confluent) were cotransfected with 3 g of promoter constructs (generated by us previously, see Refs. 14, 21, and 22) and 100 ng of the Renilla transfection control plasmid Renilla luciferase-thymidine kinase (Promega) with Lipofectamine reagent (Life Technologies) following the manufacturer's instructions. Posttransfection (4 -6 h) cells were subjected to growth in thiamine-deficient or thiamine-oversupplemented (1 mM thiamine) DMEM. Renilla-normalized firefly luciferase activity was assessed 9 days after transfection using the Dual Luciferase Assay system (Promega). Data are presented as means Ϯ SE of at least three independent experiments and given as fold over pGL3-Basic expression, which was set arbitrarily at one.
Western blot analysis. Lysates of Caco-2 cells exposed to different levels of thiamine for 9 days were separated in NuPAGE 4 -12% Bis-Tris gradient minigels (Invitrogen), transferred to immobilon polyvinylidene difluoride membrane (Fisher Scientific), and subjected to immunostaining. Anti-SP1 polyclonal (1:500 dilution) and anti-␤-actin monoclonal (1:3,000 dilution) antibody served as primary antibodies. The secondary antibodies were anti-rabbit IRDye-800 and anti-mouse IRDye-680 (both at 1:25,000 dilution). Immunoreactive bands were detected using the Odyssey infrared imaging system (LI-COR Bioscience), and their densities were determined using the LI-COR software.
EMSA. EMSA was performed using the Light Shift Chemiluminescent EMSA kit (Thermo Scientific Pierce) according to the manufacturer's instructions. Nuclear extracts were prepared from Caco-2 cells exposed to different levels of thiamine for 9 days using NE-PER Nuclear and Cytoplasmic extraction reagents (Thermo Scientific Pierce, Rockford, IL). SLC19A3 promoter fragment (5=-CGCCCG-GATTCGCATATGCAAAGCGTGGGGGCGTGGCCCCGGGCTC-CGG-3=), which corresponded to the thiamine level-responsive region, was biotin-labeled using the Biotin 3=-end DNA-labeling kit (Thermo Scientific Pierce). Binding reactions were carried out with 3 g of nuclear extract, 20 fmol of DNA probe, and 50 ng/l poly(dI·dC) for 30 min at room temperature. A 200-fold molar excess of unlabeled probe was used in competition analysis. The nuclear extract was pretreated with anti-SP1 monoclonal antibody (1 g) for the supershift assays. DNA-protein complexes, separated on 6% DNA retardation gel (Invitrogen Life Technologies) and transferred to nylon membrane, were detected by chemiluminescence using the Chemiluminescent Nucleic Acid Detection Module (Thermo Scientific Pierce).
Data presentation and statistical analysis. Uptake data are the means Ϯ SE of three independent experiments expressed in terms of femtomoles per milligram protein per 5 min. Uptake of thiamine by the carrier-mediated system was determined by subtracting uptake by passive diffusion (determined from the slope of the line between uptake at a high pharmacological concentration of 1 mM thiamine and the point of origin) from the total uptake. Real-time PCR assays, promoter assays, Western blot analyses, and EMSA were performed on three or more separate occasions with comparable results. Data were analyzed by the Student's t-test with statistical significance set at P Ͻ 0.05. Data (Western blot and EMSA) presented in this report are from a representative set of experiments.
RESULTS
Effect of thiamine deficiency and high extracellular thiamine level on thiamine uptake, expression of THTR-1 and THTR-2 mRNA, and SLC19A2 and SLC19A3 promoter activity in human intestinal Caco-2 cells.
The effect of maintaining the human-derived intestinal epithelial Caco-2 cells in thiamine-deficient growth medium or thiamine-oversupplemented (1 mM) growth medium on the initial rate of uptake of [ unrelated B vitamin biotin by Caco-2 cells was observed in respect to extracellular thiamine level (data not shown), indicating the specificity of the observed adaptive effect.
Based on our previous knowledge that the adaptive regulation of intestinal thiamine uptake by dietary thiamine levels in mice involves transcriptional mechanisms (23), we determined if the adaptive regulation of thiamine uptake by extracellular substrate observed in Caco-2 cells is also mediated via changes in the level of mRNA expression of the thiamine transporters. In this study, we examined the expression level of THTR-1 and THTR-2 mRNAs by means of real-time PCR using RNA samples obtained from cells maintained in thiamine-deficient and thiamine-oversupplemented media. The results (Fig. 1B) showed a significantly (P Ͻ 0.01; ϳ2.5-fold) higher mRNA expression level for THTR-2 in cells maintained under thiamine deficiency compared with those maintained under thiamine oversupplementation. On the other hand, no significant difference in the level of expression of THTR-1 mRNA was observed between cells exposed to thiamine deficiency and thiamine oversupplementation (Fig. 1B) . These findings suggest that the adaptive regulation in thiamine uptake is mediated via the THTR-2 (but not the THTR-1) uptake system and may involve a transcriptional mechanism. To test this possibility, we examined the effect of maintaining Caco-2 cells in thiamine-deficient and thiamine-oversupplemented growth media on promoter activity of the SLC19A2 and SLC19A3 genes (which express THTR-1 and THTR-2, respectively). In these studies, we transiently transfected Caco-2 cells with the promoter-luciferase construct containing the previously cloned 2,635-bp SLC19A2 promoter (21, 22) or the 2,016-bp SLC19A3 promoter (14) and then maintained the cells under thiamine-deficient and -oversupplemented conditions. The results showed (Fig. 1C) the activity of the SLC19A3 promoter to be significantly (P Ͻ 0.01) higher in cells exposed to the thiamine-deficient condition compared with those maintained in the presence of thiamine oversupplementation. On the other hand, no significant difference in SLC19A2 promoter activity was observed in cells maintained under thiamine-deficient or -oversupplemented conditions. These findings demonstrate that the adaptive regulation in level of expression of THTR-2 by extracellular substrate level in Caco-2 cells is mediated at the level of transcription of the SLC19A3 gene.
Determination of the thiamine level-responsive region in the SLC19A3 promoter. As a first step to determining how the SLC19A3 promoter is regulated by extracellular thiamine level, we mapped the thiamine level-responsive region in the SLC19A3 full-length (2,016-bp) promoter [this fragment corresponds to the Ϫ1,957 to ϩ59 genomic region using TSS as a ϩ1 (14)]. A 5=-deletion analysis using constructs with a variable 5=-end but a common 3=-end at nucleotide ϩ59 was used to determine the genomic region responsible for mediating the extracellular thiamine level effect. Caco-2 cells were transiently transfected with the different 5=-deletion reporter constructs and then maintained in thiamine-deficient or thiamineoversupplemented growth media followed by determination of promoter activity. The results (Fig. 2) showed that progressive deletion of nucleotides up to Ϫ77 does not lead to a disappearance of the extracellular thiamine adaptive response on promoter activity. However, deletion of the additional 48 nucleotides up to Ϫ29 virtually abolished the thiamine level-responsive effect. We concluded that the region in the SLC19A3 promoter that mediates the extracellular thiamine level adaptive response is located in a sequence between Ϫ77 and Ϫ29.
Establishment of a key role for a SP1/guanosine cytidine box binding site in mediating the effect of extracellular thiamine level on activity of the SLC19A3 promoter. The identified thiamine-responsive region of SLC19A3 promoter contains putative cis-regulatory elements for several transcriptional factors, including octamer factor 1 (OCT1), early growth response gene (EGR2/EGR3), and SP1 guanosine cytidine (GC) box 
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. Data are means Ϯ SE of 3 independent experiments. *P Ͻ 0.01. B: effect of extracellular thiamine on the level of thiamine transporter-1 (THTR-1) and thiamine transporter-2 (THTR-2) RNA expression. Total RNA was isolated from thiamine-deficient or thiamine-oversupplemented Caco-2 cells, and quantitative real-time PCR was performed as described in MATERIALS AND METHODS. Data (means Ϯ SE) are from 3 different experiments, normalized relative to ␤-actin, and given in % (with the highest expression of gene of interest set up at 100%). *P Ͻ 0.01. C: effect of extracellular thiamine level on activity of the full-length SLC19A2 and SLC19A3 promoters. Promoter constructs in pGL3-Basic were transiently expressed in Caco-2 cells maintained in thiamine-deficient and thiamine-oversupplemented conditions followed by luciferase assays. Data are reported as relative firefly luciferase activity normalized to Renilla luciferase activity and represent means Ϯ SE of at least 3 independent experiments, each performed in triplicate. *P Ͻ 0.01. (14) . This SP1 cis-regulatory element with its core located in a sequence between Ϫ48 and Ϫ45 plays an important role in governing the basal activity of the SLC19A3 promoter as has been established (14) . To study the functional contribution of the cis-regulatory elements inside the thiamine level-responsive region of SLC19A3 promoter in mediating the effect of extracellular thiamine level on promoter activity, we examined the effect of mutating these cis-elements on promoter activity in Caco-2 cells. In this study, Caco-2 cells were transiently transfected with the previously generated basal SLC19A3 promoter-luciferase constructs carrying mutated nucleotides in the core regions of the cis-elements (14) , followed by maintaining the cells in thiamine-deficient or -oversupplemented growth media. The results (Fig. 3) showed that mutating the SP1/GC box leads to disappearance of the thiamine level-induced promoter response. In contrast to the above, mutating nucleotides in the OCT1 or EGR2/EGR3 site did not affect promoter activity with respect to extracellular thiamine level, i.e., wildtype (control) and mutated constructs demonstrated the same pattern of response to extracellular thiamine level. These findings suggest a key role for SP1/GC box cis-regulatory element (region Ϫ48 to Ϫ45) in the SLC19A3 promoter response to extracellular thiamine level.
Extracellular level of thiamine affects SP1 protein expression and binding pattern to the thiamine level-responsive region of the SLC19A3 promoter in Caco-2 cells. SP1/GC box
cis-regulatory elements are widely distributed and are known to interact with the SP1-related family of transcription factors (9, 30) . Previously, we have determined that the SP1/GC box (region Ϫ48 to Ϫ45) in the SLC19A3 promoter is a target for SP1 binding (14) . Based on this knowledge, we aimed in this study to delineate the possible contribution of SP1 transcription factor to the observed regulation of SLC19A3 promoter activity by extracellular thiamine level. We first examined whether extracellular thiamine levels affect the expression of SP1 protein in Caco-2 cells. This was done by means of Western blot analysis using SP1-specific polyclonal antibodies and lysates prepared from Caco-2 cells maintained in thiaminedeficient and -oversupplemented growth medium. The results showed a significantly (P Ͻ 0.05) higher level of expression of SP1 protein in cells maintained under the thiamine-deficient condition compared with those maintained under oversupplemented conditions (Fig. 4) .
We next examined the effect of the extracellular thiamine level on the binding pattern of SP1 to the thiamine levelresponsive region of the SLC19A3 promoter by means of EMSA. The latter was performed using a 49-bp thiamine promoter. Caco-2 cells were transiently transfected with the SLC19A3 fulllength promoter (Ϫ1,957 to ϩ59) or 5=-deletions and then maintained in thiamine-deficient or thiamine-oversupplemented growth media followed by luciferase assays. Data are reported as relative firefly luciferase activity normalized to Renilla luciferase activity and represent means Ϯ SE of 3 independent experiments, each performed in triplicate. *P Ͻ 0.01 and **P Ͻ 0.05.
level-responsive region of the SLC19A3 promoter spanning a sequence between Ϫ77 and Ϫ29 and nuclear extracts isolated from Caco-2 cells exposed to different levels of thiamine. The results of EMSA performed with nuclear extracts from cells maintained under thiamine-deficient conditions showed that the thiamine level-responsive promoter region forms two prominent DNA/protein complexes with the major complex appearing as the upper shifted band (Fig. 5, lane 2) . Both complexes were found to be specifically inhibited by unlabeled probe (200-fold molar excess, lane 4). Direct confirmation of SP1 binding to the thiamine level-responsive region of the SLC19A3 promoter was obtained from supershift analysis. When the nuclear extract from thiamine-deficient cells was preincubated with the anti-SP1 monoclonal antibody, an additional band with decreased mobility (possible gel supershift) was detected with simultaneous complete disappearence of bands 1 and 2 (Fig. 5, lane 6 ), indicating that SP1 transcription factor is involved in formation of both DNA/protein complexes (bands 1 and 2). The results of EMSA performed with nuclear extracts from cells maintained in the thiamine-oversupplemented condition showed a dramatic decrease in the intensity of these two DNA/protein formations (Fig. 5, lane 3) . In addition, in the case of oversupplemented cells, the overall mobility shift pattern differed from that of thiamine-deficient cells; indeed, additional minor DNA/protein complexes with the decreased gel mobility were detected.
DISCUSSION
The aim of this study was to examine the molecular mechanism involved in the adaptive regulation of the intestinal thiamine uptake process by extracellular substrate levels. Both thiamine transporters, THTR-1 and THTR-2, contribute toward carrier-mediated intestinal thiamine uptake, and together they account for total carrier-mediated thiamine uptake by intestinal epithelial cells (26) . The design of research was based on our previous knowledge that the intestinal thiamine uptake is adaptively upregulated during dietary thiamine deficiency in mice and that this upregulation appears to occur there through a transcriptional regulatory mechanism involving THTR-2 (23). In our current study, using human intestinal epithelial Caco-2 cells exposed to different concentrations of extracellular thiamine as a model, we verified the phenomenon of adaptive regulation of human intestinal thiamine uptake by the substrate level, established that it is mediated via the THTR-2 system, and then determined how the THTR-2 system is transcriptionally regulated by substrate level. We identified the thiamine level-responsive region in the SLC19A3 promoter region, examined the role of putative cis-regulatory elements from this region in promoter regulation by substrate level, and determined the transcriptional factor important in mediating the effect of extracellular thiamine level on the SLC19A3 promoter.
Our results demonstrated an inverse correlation between thiamine uptake by Caco-2 cells and its prevailing level in the growth medium. Indeed, maintaining Caco-2 cells in a thiamine-deficient medium resulted in a specific and significant upregulation of vitamin uptake compared with cell exposure to a high level of thiamine, and it was found to be associated with the higher mRNA expression level for THTR-2 (but not THTR-1) and the higher level of activity of SLC19A3 promoter (but not SLC19A2 promoter). The latter finding suggests that the adaptive regulation in SLC19A3 gene expression is occurring at the level of transcription.
We performed further analysis of the SLC19A3 promoter role in the adaptive regulation of thiamine uptake by Caco-2 cells using various SLC19A3 promoter-luciferase reporter constructs generated by us previously (14) and identified a 49-bp thiamine level-responsive region in a promoter sequence between Ϫ77 and Ϫ29, using the transcription start site as ϩ1. This thiamine level-responsive region contains a number of cis-regulatory elements, including SP1/GC box (Ϫ48/Ϫ45 bp), which was determined by us previously to be a target for SP1 binding and to play an important role in the basal activity of the SLC19A3 promoter (14) . SP1 transcription factor represents one of the most ubiquitous C 2 H 2 -type zinc finger-containing DNA-binding proteins that controls the expression of numerous genes implicated in a variety of cell events (3, 13, 30, 32) . SP1 can bind to GC-rich motifs with high specificity and affinity, and, through interactions with the nearby transcriptional factors or components of the basal transcriptional machinery, plays a crucial role in activation/repression of transcription initiation in response to stimuli, including multiple environmental stimuli. We examined the role of SP1/GC box in regulating the activity of the SLC19A3 promoter in response to extracellular thiamine level by mutating the GGCG core tetramer and observed complete abolishment of the thiaminemediated promoter response. This SP1/GC box-mediated effect was proven to be specific since mutating of other unrelated cis-elements (such as OCT1 and EGR2/EGR3) did not affect promoter response with respect to thiamine. These findings suggest the contribution of the SP1/GC box located in the thiamine level-responsive region of the SLC19A3 promoter in the adaptive promoter response to extracellular thiamine.
Because SP1 can bind to the SP1/GC box (Ϫ48/Ϫ45 bp) (14), we then focused on assessing a possible role for this transcription factor in the SLC19A3 promoter response to changes in extracellular thiamine level. SP1 can alter gene expression via a variety of mechanisms that include modulation in its level of expression or its posttranslational modification (3, 13, 32) . We found that the extracellular level of thiamine affects cellular SP1 protein expression; indeed, our results showed enhanced SP1 protein expression in cells maintained in the thiamine-deficient condition compared with those exposed to a high level of thiamine. These data indicate that modulation of SP1 protein expression can serve as a mechanism (or at least one of the mechanisms) responsible for alterations in SLC19A3 expression induced by extracellular thiamine level. EMSA studies using the thiamine level-responsive SLC19A3 promoter region and nuclear extracts from Caco-2 cells maintained in thiamine-deficient and -oversupplemented conditions has confirmed this suggestion, since it showed a marked reduction in the intensity of the DNA/protein complexes in the case of the oversupplemented condition. Meantime, we cannot completely exclude the possibility that extracellular thiamine level also induces changes in posttranslational modifications of SP1, which then affect its interaction with the promoter and EMSA pattern. Further studies are needed to address this issue.
In conclusion, this study demonstrates that human intestinal thiamine uptake is adaptively regulated by the extracellular substrate level via a transcriptional mechanism involving the THTR-2 system; the study also shows that the SP1 transcriptional factor is involved in this regulation.
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